Reuters logo
BRIEF-MiMedx notified by FDA to proceed with phase 3 trial for Achilles Tendonitis
September 7, 2017 / 11:57 AM / 17 days ago

BRIEF-MiMedx notified by FDA to proceed with phase 3 trial for Achilles Tendonitis

Sept 7 (Reuters) - MiMedx Group Inc

* MiMedx notified by FDA that it can proceed with phase 3 investigational new drug clinical trial for Achilles Tendonitis

* MiMedx Group Inc - ‍company expects patient enrollment to commence in next quarter.​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below